Published in J Neurosci Res on December 01, 1990
TNF alpha affects the expression of GFAP and S100B: implications for Alzheimer's disease. J Neural Transm (Vienna) (2006) 0.87
Golgi apparatus, GERL, and lysosomes of neurons in rat dorsal root ganglia, studied by thick section and thin section cytochemistry. J Cell Biol (1971) 5.94
A new obligately chemolithoautotrophic, nitrite-oxidizing bacterium, Nitrospira moscoviensis sp. nov. and its phylogenetic relationship. Arch Microbiol (1995) 4.02
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol (1997) 3.80
Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science (1997) 3.68
Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet (2000) 3.42
Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol (2002) 3.02
Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol (1996) 2.68
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol (1994) 2.65
Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain (1991) 2.52
Chromosome 9p-linked families with frontotemporal dementia associated with motor neuron disease. Neurology (2009) 2.46
Large amounts of neocortical beta A4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person. Neurosci Lett (1990) 2.40
Primary central nervous system lymphomas in 72 immunocompetent patients: pathologic findings and clinical correlations. Groupe Ouest Est d'étude des Leucénies et Autres Maladies du Sang (GOELAMS) Am J Clin Pathol (1998) 2.35
BSE transmission to macaques. Nature (1996) 2.32
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem (1989) 2.26
Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology (2004) 2.23
Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells. Mol Cell Biol (1998) 2.22
Sporadic Creutzfeldt-Jakob disease mimicking nonconvulsive status epilepticus. Neurology (2010) 2.17
Paramedian thalamic and midbrain infarct: clinical and neuropathological study. Ann Neurol (1981) 2.10
Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol (1995) 2.10
Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol (1996) 2.09
Valosin-containing protein gene mutations: clinical and neuropathologic features. Neurology (2006) 2.00
Molecular forms of acetylcholine receptor. Effects of calcium ions and a sulfhydryl reagent on the occurrence of oligomers. Biochemistry (1977) 1.98
Rating of the lesions in senile dementia of the Alzheimer type: concordance between laboratories. A European multicenter study under the auspices of EURAGE. J Neurol Sci (1990) 1.96
[Anatomy of the cerebellar arteries]. Rev Neurol (Paris) (1989) 1.96
Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control. J Biol Chem (1992) 1.92
Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content? J Neurochem (1992) 1.91
A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics. Nature (1987) 1.91
Does amyloid precede paired helical filaments in the senile plaque? A study of 15 cases with graded intellectual status in aging and Alzheimer disease. Neurosci Lett (1988) 1.89
Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases) Brain Pathol (1995) 1.86
Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease. Proc Natl Acad Sci U S A (1998) 1.85
Interaction of beta-iodopenicillanate with the beta-lactamases of Streptomyces albus G and Actinomadura R39. Biochem J (1982) 1.84
Compassionate use of quinacrine in Creutzfeldt-Jakob disease fails to show significant effects. Neurology (2004) 1.82
The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med (1992) 1.80
"Inflammatory" cytokines: neuromodulators in normal brain? J Neurochem (2000) 1.80
Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol (1996) 1.77
Interaction of clavulanate with the beta-lactamases of Streptomyces albus G and Actinomadura R39. Biochem J (1982) 1.74
Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci Lett (1994) 1.73
The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor. Oncogene (2001) 1.72
Nitrification at Low pH by Aggregated Chemolithotrophic Bacteria. Appl Environ Microbiol (1991) 1.68
Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res (1983) 1.67
Glial cells express N-CAM/D2-CAM-like polypeptides in vitro. Nature (1985) 1.66
Neuroendocrine primary small cell carcinoma of the breast. Report of a case and review of the literature. Am J Clin Oncol (1995) 1.66
Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum Mol Genet (1998) 1.64
Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults. J Inherit Metab Dis (2007) 1.64
Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci U S A (1987) 1.62
Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia. Nat Med (1999) 1.61
Cytoarchitectonic alterations in the supramarginal gyrus of late onset Alzheimer's disease. Acta Neuropathol (1998) 1.59
Identification and quantitation of antigens and antibodies by means of quantitative immunoelectrophoresis. A survey of methods. J Immunol Methods (1972) 1.58
HIV-1-associated cognitive/motor complex: absence of neuronal loss in the cerebral neocortex. Neurology (1993) 1.56
High residual arylsulfatase A (ARSA) activity in a patient with late-infantile metachromatic leukodystrophy. Am J Hum Genet (1993) 1.55
Cannabinoid-receptor expression in human leukocytes. Eur J Biochem (1993) 1.53
Absence of the major dense line in myelin of the mutant mouse "shiverer". Neurosci Lett (1979) 1.53
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol Psychiatry (2009) 1.51
Perineuronal nets provide a polyanionic, glia-associated form of microenvironment around certain neurons in many parts of the rat brain. Glia (1993) 1.49
Oligodendroglial and neuronal inclusions in multiple system atrophy. Curr Opin Neurol (1993) 1.47
Impaired brain development and hydrocephalus in a line of transgenic mice with liver-specific expression of human insulin-like growth factor binding protein-1. Growth Horm IGF Res (2000) 1.47
Demonstration of immunochemical identity between the nerve growth factor-inducible large external (NILE) glycoprotein and the cell adhesion molecule L1. EMBO J (1985) 1.46
Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-- Jakob disease: implications for human health. Proc Natl Acad Sci U S A (2001) 1.46
Expression of neural cell adhesion molecule-related sialoglycoprotein in small cell lung cancer and neuroblastoma cell lines H69 and CHP-212. Cancer Res (1990) 1.46
Role of pontine nuclei damage in smooth pursuit impairment of progressive supranuclear palsy: a clinical-pathologic study. Neurology (1994) 1.46
[Immunochemical estimation of IgG and albumin in cerebrospinal fluid]. Clin Chim Acta (1972) 1.44
Sporadic CJD clinically mimicking variant CJD with bilateral increased signal in the pulvinar. Neurology (2002) 1.43
Cytokine signals propagate through the brain. Mol Psychiatry (2000) 1.42
The neural cell adhesion molecule L1 is distinct from the N-CAM related group of surface antigens BSP-2 and D2. EMBO J (1984) 1.40
Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia. Brain Res (1982) 1.40
Prevalence, incidence and duration of Braak's stages in the general population: can we know? Neurobiol Aging (1997) 1.39
Neural cell adhesion molecule-stimulated neurite outgrowth depends on activation of protein kinase C and the Ras-mitogen-activated protein kinase pathway. J Neurosci (2000) 1.38
Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates. Neurology (2000) 1.36
A simple procedure for quantification of neurite outgrowth based on stereological principles. J Neurosci Methods (2000) 1.36
Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro. Int J Cancer (1996) 1.36
Molecular cloning of a levocabastine-sensitive neurotensin binding site. FEBS Lett (1996) 1.32
Is the mesocortical dopaminergic system involved in Parkinson disease? Neurology (1980) 1.32
Postnatal development of perineuronal nets in wild-type mice and in a mutant deficient in tenascin-R. J Comp Neurol (2000) 1.31
[Amiodaron neuropathy: clinical and pathological study of a new drug induced lipidosis (author's transl)]. Rev Neurol (Paris) (1980) 1.31
Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med (2013) 1.31
Laminar distribution of neocortical senile plaques in senile dementia of the Alzheimer type. Acta Neuropathol (1986) 1.29
Human immunodeficiency virus (HIV) leukoencephalopathy and the microcirculation. J Neuropathol Exp Neurol (1990) 1.29
Oligomeric forms of the metastasis-related Mts1 (S100A4) protein stimulate neuronal differentiation in cultures of rat hippocampal neurons. J Biol Chem (2000) 1.29
Fatal familial insomnia: clinical and pathologic study of five new cases. Neurology (1992) 1.29
Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type. Acta Neuropathol (1991) 1.28
Immunochemical studies of myelin basic protein in shiverer mouse devoid of major dense line of myelin. Neurosci Lett (1979) 1.28
Even in culture, oligodendrocytes myelinate solely axons. Proc Natl Acad Sci U S A (1993) 1.28
Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies. Eur J Neurol (1999) 1.28
Glutathione peroxidase, glial cells and Parkinson's disease. Neuroscience (1993) 1.27
Dopaminergic and cholinergic lesions in progressive supranuclear palsy. Ann Neurol (1985) 1.26
Letter: Absence of ASA activity in healthy father of a patient with metachromatic leukodystrophy. N Engl J Med (1975) 1.25